Gene · 1301
Papers2,518
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,518
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gene expression profiling of extraocular muscles in primary inferior oblique overaction. | PeerJ | 2025 | 40452936 | PubTator, text mining | PubMed |
| Two cases of autosomal dominant familial short stature associated with COL11A2 gene variant and the therapeutic response to recombinant human growth hormone. | Transl Pediatr | 2025 | 40386356 | PubTator, text mining | PubMed |
| Role of tumor microenvironment in ovarian cancer metastasis and clinical advancements. | J Transl Med | 2025 | 40369674 | PubTator, text mining | PubMed |
| A novel exploration of COL11A1's role in regulating myeloid-derived suppressor cell activation within the colon cancer microenvironment. | J Pharm Anal | 2025 | 40337128 | PubTator, text mining | PubMed |
| Impact of COL11A1 Mutations on Tumor Mutational Signatures and Immune Microenvironment in Head and Neck Squamous Cell Carcinoma. | Cureus | 2025 | 40322427 | PubTator, text mining | PubMed |
| Genetic and clinical profile of high myopia patients with rhegmatogenous retinal detachment. | Front Genet | 2025 | 40270540 | PubTator, text mining | PubMed |
| Mechanism of etoposide resistance in small cell lung cancer and the potential therapeutic options. | Med Oncol | 2025 | 40257680 | PubTator, text mining | PubMed |
| Whole-exome sequencing screening for candidate genes and potential pathogenic variants associated with early-onset high myopia in 47 Chinese families. | Sci Rep | 2025 | 40175531 | PubTator, text mining | PubMed |
| Transitional CXCL14+ cancer-associated fibroblasts enhance tumour metastasis and confer resistance to EGFR-TKIs, revealing therapeutic vulnerability to filgotinib in lung adenocarcinoma. | Clin Transl Med | 2025 | 40162549 | PubTator, text mining | PubMed |
| Inflammatory profiling and immune cell infiltration in dysthyroid optic neuropathy: insights from bulk RNA sequencing. | Front Immunol | 2025 | 40160813 | PubTator, text mining | PubMed |
| Whole exome sequencing of 80 cases of sporadic mitral valve prolapse reveals novel disease-associated genes and variants in a Southern Chinese population. | Genes Genomics | 2025 | 40131712 | PubTator, text mining | PubMed |
| ITGA8 deficiency in hepatic stellate cells attenuates CCl4-Induced liver fibrosis via suppression of COL11A1. | Biochem Biophys Res Commun | 2025 | 40056500 | PubTator, text mining | PubMed |
| Molecular subtyping of stage I lung adenocarcinoma via molecular alterations in pre-invasive lesion progression. | J Transl Med | 2025 | 40038757 | PubTator, text mining | PubMed |
| SPP1hi macrophages, NKG7 T cells, CCL5hi fibroblasts, and IgM plasma cells are dominant features of necrobiosis. | JCI Insight | 2025 | 39989459 | PubTator, text mining | PubMed |
| Knowledge of the genetics of human pain gained over the last decade from next-generation sequencing. | Pharmacol Res | 2025 | 39988004 | PubTator, text mining | PubMed |
| Phage parasites targeting phage homologous recombinases provide antiviral immunity. | Nat Commun | 2025 | 39987160 | PubTator, text mining | PubMed |
| An Unusual Retinal Presentation of a Novel COL11A1 Mutation: A Case Report. | Case Rep Ophthalmol | 2025 | 39981533 | PubTator, text mining | PubMed |
| A cross-sectional study on the assessment of COLL11A1, VEGF, and GDF5 gene polymorphisms in Turkish patients with primary knee osteoarthritis. | BMC Musculoskelet Disord | 2025 | 39953483 | PubTator, text mining | PubMed |
| The FUS/COL11A1/ZEB1 Axis Contributes to the Development of Oral Squamous Cell Carcinoma. | J Oral Pathol Med | 2025 | 39915978 | PubTator, text mining | PubMed |
| Differential gene expression analysis and machine learning identified structural, TFs, cytokine and glycoproteins, including SOX2, TOP2A, SPP1, COL1A1, and TIMP1 as potential drivers of lung cancer. | Biomarkers | 2025 | 39888730 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1301/papers?page=7